Actividad Investigadora
Documento de consenso de asma grave. Actualización 2025.
Autores de IDIVAL
Autores ajenos al IDIVAL
- Álvarez-Gutiérrez FJ
- Blanco Aparicio M
- Casas Maldonado F
- Plaza V
- Soto Campos G
- González-Barcala FJ
- Almonacid C
- Arismendi E
- Cabrera C
- Cabestre García R
- Carretero JÁ
- Castilla Martínez M
- Castillo Vizuete JA
- Cisneros Serrano C
- Díaz de Atauri ÁG
- Diaz Pérez D
- Domingo Ribas C
- López Neyra A
- Martínez Moragón E
- de Mir Messa I
- Muñoz Gall X
- Padilla Galo A
- Perpiñá Tordera M
- Pérez de Llano L
- Sánchez Toril F
- Sanz Santiago V
- Valverde Molina J
Unidades
Abstract
Severe asthma is a heterogeneous syndrome with several clinical variants and often represents a complex disease requiring a specialized and multidisciplinary approach, as well as the use of multiple drugs. The prevalence of severe asthma varies from one country to another, and it is estimated that 50% of these patients present a poor control of their disease. For the best management of the patient, it is necessary to have a correct diagnosis, an adequate follow-up and undoubtedly to offer the best available treatment, including biologic treatments with monoclonal antibodies. With this objective, this consensus process was born, which began in its first version in 2018, whose goal is to offer the patient the best possible management of their disease to minimize their symptomatology. For this 2025 consensus update, a literature review was conducted by the authors, and new sections of how to treat asthma comorbidities or pediatric asthma were added, as a paragraph about monoclonal antibody switch. Subsequently, through a two-round interactive Delphi process, a broad panel of asthma experts from SEPAR and the regional pulmonology societies proposed the recommendations and conclusions contained in this document.
© 2025 Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Published by Elsevier España, S.L.U.
Datos de la publicación
- ISSN/ISSNe:
- 2659-6636, 2659-6636
- Tipo:
- Article
- Páginas:
- 100486-100486
- PubMed:
- 41049458
Open Respiratory Archives
Documentos
- No hay documentos
Filiaciones
Keywords
- Diagnosis; Follow-up; Monoclonal antibodies; Severe asthma; Treatment
Cita
Álvarez FJ, Blanco M, Casas F, Plaza V, Soto G, González FJ, Almonacid C, Arismendi E, Cabrera C, Cabestre R, Carretero JÁ, Castilla M, Castillo JA, Cisneros C, Díaz de Atauri ÁG, Diaz D, Domingo C, García JL, López A, Martínez E, de Mir I, Muñoz X, Padilla A, Perpiñá M, Pérez de Llano L, Sánchez F, Sanz V, Valverde J. Documento de consenso de asma grave. Actualización 2025. Open Respir Arch. 2025. 7. (4):p. 100486-100486.
